Concepedia

Three-Dimensional Echocardiographic and Magnetic Resonance Assessment of the Effect of Telmisartan Compared With Carvedilol on Left Ventricular MassA Multicenter, Randomized, Longitudinal Study

Domenico Galzerano, Paolo Tammaro, L DELVISCOVO, D. Lama, António Galzerano, R Breglio, Bernardino Tuccillo, Giuseppe Paolisso, Paolo Capogrosso

American Journal of Hypertension · 2005 · 72 citations · 16 references

DOI

Abstract

The superior LVM regression with telmisartan versus carvedilol suggests telmisartan has a mechanism that may be beyond that of lowering BP in hypertensive patients.

References

16

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

Björn Dahlöf, Richard B. Devereux, Sverre E. Kjeldsen et al. · The Lancet · 2002 · 5.4K citations

, , +7

Reduction in Sample Size for Studies of Remodeling in Heart Failure by the Use of Cardiovascular Magnetic Resonance

Nicholas G. Bellenger, Ceri Davies, Jane M Francis et al. · Journal of Cardiovascular Magnetic Resonance · 2000 · 678 citations

, , +11

Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Treatment and the Prediction of Major Cardiovascular Events

Peter M. Okin · JAMA · 2004 · 657 citations

Regression of Hypertensive Left Ventricular Hypertrophy by Losartan Compared With Atenolol

Richard B. Devereux, Björn Dahlöf, Eva Gerdts et al. · Circulation · 2004 · 466 citations

Rationale, design, and baseline characteristics of 2 large, simple, randomized trials evaluating telmisartan, ramipril, and their combination in high-risk patients: the Ongoing Telmisartan Alone and in Combination with Ramipril Global Endpoint Trial/Telmisartan Randomized Assessment Study in ACE Intolerant Subjects with Cardiovascular Disease (ONTARGET/TRANSCEND) trials

Koon Teo, Salim Yusuf, Peter Sleight et al. · American Heart Journal · 2004 · 382 citations

, , +11